Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer

Published:2011-12-12 Issue:37 Volume:31 Page:4139-4149
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Alberti C,Pinciroli P,Valeri B,Ferri R,Ditto A,Umezawa K,Sensi M,Canevari S,Tomassetti A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011572.pdf

Reference35 articles.

1. Anglesio MS, Arnold JM, George J, Tinker AV, Tothill R, Waddell N et al. (2008). Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Mol Cancer Res 6: 1678–1690.

2. Bast Jr RC, Hennessy B, Mills GB. (2009). The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9: 415–428.

3. Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA et al. (2009). Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res 15: 2448–2455.

4. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D et al. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353–357.

5. Braun AH, Coffey RJ. (2005). Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last. Clin Cancer Res 11: 4639–4643.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protease ADAMTS5 controls ovarian cancer cell invasion, downstream of Rab25;2024-07-08

2. Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses;British Journal of Cancer;2024-04-15

3. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment;International Journal of Molecular Sciences;2024-03-02

4. Correlation between pre-operative platelets count and serum cancer antigen-125 level in epithelial ovarian carcer;Indian Journal of Obstetrics and Gynecology Research;2024-02-15

5. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3